Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Prudential accelerates buyback as 2024 profits jump 10%

(Sharecast News) - Prudential has hiked its dividend by 13% and accelerated its share buyback plan after profits rose by a tenth in 2024, with financial results in line with group guidance. The insurance and asset management company returned $785m to shareholders in 2024, and a further $260m since then, as part of its $2bn repurchase plan that will now complete by the end of 2025, ahead of the original mid-2026 schedule.

The second interim dividend was 16.29 cents per share, taking the total payout for the year to 23.13 cents, up from 20.47 cents paid out in 2023.

The firm reported an adjusted operating profit before tax of $3.13bn for 2024, up 10% on a constant exchange rate (CER) basis. New business profit was up 11% CER at $3.08bn.

Bancassurance new business profit was 31% higher than the previous year, as margins benefitted from a higher contribution to APE sales from Health and Protection products. Meanwhile, Health new business profit was up 11%, supported by new healthcare products, repricing initiatives and further training and enablement of the agency force, the company said.

Operating free surplus generated from in-force insurance and asset management business was down 4% CER at $2.64bn, but the company believes 2025 will be an inflection point for growth in this measure.

For 2025, Prudential also guided to more than 10% CER growth in new business profit, adjusted earnings per share and operating free surplus generated from in-force insurance and asset management business. It also expects its dividend to increase by "at least 10%".

"The long-term growth trends inherent in our Asia and Africa markets are reasserting themselves, creating significant opportunities for us," said chief executive Anil Wadhwani.

"Insurance penetration rates in Asia are low and there is continued, and growing, demand for long term savings and protection products across our markets, alongside a need for wealth management and retirement planning, particularly in our higher income Asian markets."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.